Article
Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
23 Mar 2019
Abstract excerpt
High grade serous ovarian cancer (HGSOC) is the most common epithelial ovarian cancer, harbouring more than 20% germline or somatic mutations in the tumour suppressor genes BRCA1 and BRCA2. These genes are involved in both DNA damage repair process via homologous recombination (HR) and transcriptional regulation. BRCA mutation confers distinct characteristics, including an increased response to DNA-damaging...
Topics
Join the communities discussing this publication.